Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial
about
Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cellsProbiotics for treatment of Clostridium difficile-associated colitis in adultsSystematic review and meta-analysis of Saccharomyces boulardii in adult patientsBench-to-bedside review: Clostridium difficile colitisComparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infectionsClinical Uses of ProbioticsDevelopment of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agentProbiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysisModulation of microbiota as treatment for intestinal inflammatory disorders: An uptodateReview on microbiota and effectiveness of probiotics use in olderIdentification and characterisation of an iron-responsive candidate probioticClostridium difficile Infection and Fecal Microbiota Transplant.An update on the use and investigation of probiotics in health and disease.Lactic acid production by Streptococcus thermophilus alters Clostridium difficile infection and in vitro Toxin A productionEnteric pathogens through life stages.Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial.Mismatch between Probiotic Benefits in Trials versus Food ProductsImmunomodulatory activity of two potential probiotic strains in LPS-stimulated HT-29 cellsIn vitro and in vivo antagonistic activity of new probiotic culture against Clostridium difficile and Clostridium perfringens.Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trialThe interplay between host immune cells and gut microbiota in chronic inflammatory diseasesClostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition.Antibiotic precautions in athletesAnti-inflammatory and Intestinal Barrier-protective Activities of Commensal Lactobacilli and Bifidobacteria in Thoroughbreds: Role of Probiotics in Diarrhea Prevention in Neonatal Thoroughbreds.Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics eraEffects of probiotics on acquisition and spread of multiresistant enterococci.Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial.Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis.Data mining the human gut microbiota for therapeutic targets.Effects of probiotics and antibiotics on the intestinal homeostasis in a computer controlled model of the large intestine.Probiotics in clostridium difficile Infection.Clostridium difficile colitis: a review.Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases?The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures.Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study.Recommendations for probiotic use in humans-a 2014 updateCommercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea.Emergency subtotal colectomy for fulminant Clostridium difficile colitis--is a surgical solution considered for all patients?Probiotics improve bowel movements in hospitalized elderly patients--the PROAGE study.Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective.
P2860
Q21198789-2BB34B4F-6A81-442A-B59F-5EE9CFE1E833Q24242821-1027A09F-E145-4FD1-8165-AEF922C2D970Q24621081-C7828F71-9FBF-4929-AA9C-FC5291AE9530Q24644191-00CDF474-0506-4545-A5DD-16B666380F9EQ26752760-A15DBFC9-3ABB-4DC1-98C9-F2CB7DE6FBC0Q26769032-CE2490AC-AC60-4CA2-91CC-CC5E0B1723DAQ26991504-EA9952FF-589B-4218-9006-68551A1A300EQ27015021-79D26745-A45B-4310-A296-4661D0469D78Q28072437-B66A4B0D-4567-4606-A740-807849FE5B44Q28082705-78BB8A9F-8405-4DF1-B9FD-6A6E5FC069E7Q28743610-3D3D958B-2F0A-47D3-8785-8DAB8335EDA9Q30240065-8798E89E-32C3-43C2-AE2A-6AC519D21CD8Q30407565-2403BFCF-C11E-4864-A228-A7E93FF4A94BQ30416554-5F01A9D6-9099-4831-9702-C36108975D5FQ30425379-915AF517-C6F8-467B-9407-C08FF7A8D88EQ33502385-683341D6-0780-447B-8791-83A93D2BFC6FQ33616944-6C2131F6-3402-4D9D-A2C0-1CDDE468F2D2Q33632901-1F7CC9ED-9BF0-4025-B310-4885E83B209CQ33645383-0BE608EB-CA6C-45DE-9282-EE06B9C2CA90Q33668674-2B865BDE-1A3C-4FF8-9BF7-941F9A18C6F2Q33754027-B15B4B49-B4CB-4D68-BBAD-2459A1BAE22BQ33777945-C5F63844-E41D-43D8-BCC2-441B3838BB38Q33786181-928DBD44-D8A5-4F1C-B480-4D982EAA0CCFQ33875973-46F9235C-423E-4FBF-BA92-A43EBA8CC776Q33939802-94190870-4167-42D0-AC1D-255A1608C9E7Q33962888-3478693E-9A50-4689-9C5B-7DE5B1BBE1CDQ34005969-D7260C4A-634C-45C5-A6B4-CB770EBB7543Q34094620-5B6197D3-08B5-44EE-94F4-F0C8AA289399Q34207728-7354F4EC-77C4-40CF-BD87-683408A4B8ADQ34209418-60FBA7D1-C10B-431A-AEA8-2496AB446DDEQ34223543-67097A10-AEBF-4177-88BB-DAFE3AA7450DQ34260389-542C18EF-80BD-4150-BE17-A847E5F4822AQ34286137-7798B9F2-5086-4AF1-9296-1936467A0FE8Q34309689-D01AB5DB-5AD5-4AA9-A28F-AC7E640FA65DQ34369059-6881AFF4-554F-43E7-A924-E88A53F87561Q34411373-ABA95AE7-613A-4A91-8C56-D3A68C466FD9Q34499198-9FF1F4AE-DC28-4DF4-BEEF-E4BA00DB65B8Q34508615-2F72DEDD-4703-4CA2-991B-082DD740043EQ34627337-86679D05-EE03-47FB-8DB6-F85A9D434DD9Q34629039-83226B79-45E3-4F63-9BFE-CCA0C591DB62
P2860
Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Use of probiotic Lactobacillus ...... blind placebo controlled trial
@ast
Use of probiotic Lactobacillus ...... blind placebo controlled trial
@en
type
label
Use of probiotic Lactobacillus ...... blind placebo controlled trial
@ast
Use of probiotic Lactobacillus ...... blind placebo controlled trial
@en
prefLabel
Use of probiotic Lactobacillus ...... blind placebo controlled trial
@ast
Use of probiotic Lactobacillus ...... blind placebo controlled trial
@en
P2093
P2860
P921
P1433
P1476
Use of probiotic Lactobacillus ...... blind placebo controlled trial
@en
P2093
A. L D'Souza
C. J Bulpitt
C. Rajkumar
T. R Rogers
P2860
P356
10.1136/BMJ.39231.599815.55
P407
P50
P577
2007-07-14T00:00:00Z